Preimplantation Genetic Testing Market Size, Share, By Component [(Product (Reagents & Kits, Instruments, and Software) and Services)], Procedure (Screening and Diagnosis), Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Flu
Description
Preimplantation Genetic Testing Market Size, Share, By Component [(Product (Reagents & Kits, Instruments, and Software) and Services)], Procedure (Screening and Diagnosis), Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Single Nucleotide Polymorphism, Validation Biomarkers, and Others), Application (Chromosomal Abnormalities, X-Linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, and Others), End User (Fertility Centers, Hospitals, Diagnostic Centers, and Others), and Region - Trends, Analysis and Forecast till 2035
The Preimplantation Genetic Testing Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Preimplantation genetic testing (PGT) is a screening procedure for genetic anomalies in embryos. The preimplantation genetic testing market growth is driven by factors such as increasing infertility, public awareness, adoption of Assisted Reproductive Technologies, and focus on embryo quality. Advancements in genetic analysis techniques and non-invasive PGT technologies make it more accessible and effective, ensuring healthy pregnancies.
Report Highlights:
Preimplantation genetic testing market size is valuated at USD 1.0 Billion in 2025.
Target Market size is estimated to develop at a valuation of USD 2.7 Billion by 2035 and at a CAGR of 11.5%.
Appertaining from component, the product segment is expected to govern the preimplantation genetic testing market share.
Stemming from procedure, the preimplantation genetic screening is the procedure which is ruling over the target market.
On the basis of technology, the next generation sequencing (NGS) segment is influencing the preimplantation genetic testing market.
Application-wise, the aneuploidy screening segment is projected to hold the upper hand in the preimplantation genetic testing market.
Based on end user, the fertility centers are the end users which are anticipated to hold the superior position in the target market.
Geographically, North America is the region which is attributed to dominate the preimplantation genetic testing market share.
Europe is the region which has fastest growing preimplantation genetic testing market, during the forecast period.
Key Highlights:
Preimplantation Genetic Diagnosis:
By Component:
Instruments
Software
Canada
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
Mexico
Argentina
Rest of Latin America
Israel
South Africa
Rest of the Middle East & Africa
The report also includes a competitive analysis with a detailed SWOT review, examining the strengths, weaknesses, opportunities, and threats of each leading company, as well as their market share and product offerings.
Preimplantation Genetic Testing Market Companies:
Natera, Inc.
Quest Diagnostics Incorporated
Illumina, Inc.
Revvity
CooperSurgical
Agilent Technologies, Inc.
Invitae Corporation
Fulgent Genetics
Diagnóstica Longwood SL
Genea Pty Limited
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
Igenomix
Bioarray S.L.
What Our Report Delivers:
Key Questions Answered in the Report.
What was the Preimplantation Genetic Testing Market size in 2025?
What is projected growth rate of the Preimplantation Genetic Testing Market during 2025-2035?
What are the key factors driving the Preimplantation Genetic Testing Market growth?
What are leading players in the Preimplantation Genetic Testing Market ?
What are the key regions analyzed in the Preimplantation Genetic Testing Market ?
Which region is dominating in the Preimplantation Genetic Testing Market ?
The Preimplantation Genetic Testing Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
Preimplantation genetic testing (PGT) is a screening procedure for genetic anomalies in embryos. The preimplantation genetic testing market growth is driven by factors such as increasing infertility, public awareness, adoption of Assisted Reproductive Technologies, and focus on embryo quality. Advancements in genetic analysis techniques and non-invasive PGT technologies make it more accessible and effective, ensuring healthy pregnancies.
Report Highlights:
Preimplantation genetic testing market size is valuated at USD 1.0 Billion in 2025.
Target Market size is estimated to develop at a valuation of USD 2.7 Billion by 2035 and at a CAGR of 11.5%.
Appertaining from component, the product segment is expected to govern the preimplantation genetic testing market share.
Stemming from procedure, the preimplantation genetic screening is the procedure which is ruling over the target market.
On the basis of technology, the next generation sequencing (NGS) segment is influencing the preimplantation genetic testing market.
Application-wise, the aneuploidy screening segment is projected to hold the upper hand in the preimplantation genetic testing market.
Based on end user, the fertility centers are the end users which are anticipated to hold the superior position in the target market.
Geographically, North America is the region which is attributed to dominate the preimplantation genetic testing market share.
Europe is the region which has fastest growing preimplantation genetic testing market, during the forecast period.
Key Highlights:
- In January 2025, Bionano Genomics, Inc., announced publication of a case study from the Shenzhen Maternity and Child Healthcare Hospital, China, demonstrating the application of optical genome mapping (OGM) in a protocol for preimplantation genetic testing for structural rearrangements (PGT-SR). In-vitro fertilization (IVF) and the PGT-SR protocol, which included OGM, led to selection of the presumed most viable embryos, resulting in a viable pregnancy and the birth of a healthy baby to a couple experiencing years of recurrent pregnancy loss (RPL).
Preimplantation Genetic Diagnosis:
- Preimplantation genetic diagnosis (PGD) is a specialized technique that can help couples who have an increased chance of having a child with a genetic condition. Some people choose to have PGD with IVF rather than trying for a natural pregnancy with the option of genetic testing of an ongoing pregnancy.
By Component:
- Product
Instruments
Software
- Services
- Screening
- Diagnosis
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescent In-Situ Hybridization (FISH)
- Single Nucleotide Polymorphism
- Validation Biomarkers
- Others
- Chromosomal Abnormalities
- X-linked Diseases
- Embryo Testing
- Aneuploidy Screening
- HLA Typing
- Others
- Fertility Centers
- Hospitals
- Diagnostic Centers
- Others
- North America
Canada
- Europe
U.K.
France
Russia
Italy
Spain
Netherlands
Rest of Europe
- Asia Pacific
India
Japan
Australia
Indonesia
Malaysia
South Korea
Rest of Asia Pacific
- Latin America
Mexico
Argentina
Rest of Latin America
- Middle East & Africa
Israel
South Africa
Rest of the Middle East & Africa
The report also includes a competitive analysis with a detailed SWOT review, examining the strengths, weaknesses, opportunities, and threats of each leading company, as well as their market share and product offerings.
Preimplantation Genetic Testing Market Companies:
Natera, Inc.
Quest Diagnostics Incorporated
Illumina, Inc.
Revvity
CooperSurgical
Agilent Technologies, Inc.
Invitae Corporation
Fulgent Genetics
Diagnóstica Longwood SL
Genea Pty Limited
Laboratory Corporation of America Holdings
Thermo Fisher Scientific Inc.
Igenomix
Bioarray S.L.
What Our Report Delivers:
- Regional & Country-Level Market Insights: Detailed market share analysis across key regions and countries to help you understand competitive positioning.
- Guidance for New Market Players: Actionable strategic recommendations for businesses entering the market, ensuring a strong foothold from the start.
- Comprehensive Market Forecasts: Reliable data projections for 2024, 2025, 2026, 2028, and 2032 to support long-term planning and investment decisions.
- In-Depth Market Dynamics: Analysis of drivers, restraints, opportunities, and emerging threats, along with challenges and high-potential investment areas.
- Data-Driven Business Strategies: Expert recommendations tailored to key market segments, backed by precise market evaluations.
- Competitive Intelligence: Mapping of prevailing industry trends and competitor strategies to identify growth opportunities.
- Detailed Company Profiles: In-depth analysis of major players, including their business strategies, financial performance, and recent developments.
- Supply Chain Innovations: Insights into the latest technological advancements and trends shaping supply chain efficiency.
Key Questions Answered in the Report.
What was the Preimplantation Genetic Testing Market size in 2025?
What is projected growth rate of the Preimplantation Genetic Testing Market during 2025-2035?
What are the key factors driving the Preimplantation Genetic Testing Market growth?
What are leading players in the Preimplantation Genetic Testing Market ?
What are the key regions analyzed in the Preimplantation Genetic Testing Market ?
Which region is dominating in the Preimplantation Genetic Testing Market ?
Table of Contents
170 Pages
- Preimplantation Genetic Testing Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Component
- Market Snippet, By Procedure
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Product Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Advance Technologies
- Market Segmentation, By Component, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Product
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Reagents & Kits
- Instruments
- Software
- Services
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Procedure, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Screening
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnosis
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Technology, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Next Generation Sequencing (NGS)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Polymerase Chain Reaction (PCR)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Fluorescent In-Situ Hybridization (FISH)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Single Nucleotide Polymorphism
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Validation Biomarkers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Chromosomal Abnormalities
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- X-linked Diseases
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Embryo Testing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Aneuploidy Screening
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- HLA Typing
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End User, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Fertility Centers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Hospitals
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnostic Centers
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (USD Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Procedure, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- U.S
- Canada
- Asia Pacific
- Market Size and Forecast (USD Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Procedure, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- China
- India
- Japan
- Australia
- Indonesia
- Malaysia
- South Korea
- Rest of Asia Pacific
- Europe
- Market Size and Forecast (USD Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Procedure, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
- Latin America
- Market Size and Forecast (USD Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Procedure, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (USD Bn), By Component, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Procedure, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Technology, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
